Andtbacka RH, Ross M, Agarwala SS, et al. A phase II multicentre trial of HF10, oncolytic virus immunotherapy, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma. SMR 2017, abstract SMR04-2.
Lenvatinib plus pembrolizumab bij gevorderd melanoom met ziekteprogressie
aug 2022 | Dermato-oncologie